Research ArticleOriginal Article
Open Access

Atypical meningiomas compared to other WHO Grade 2 meningiomas: Histological features and prognosis

Abdulrazag Ajlan, Saif Almeshari, Sarah Basindwah, Majed Aljohani, Yazed Alharbi, Fahad Aldhowaihy, Hisham Alkhaldi and Ashwag Alqurashi
Neurosciences Journal April 2024, 29 (2) 96-102; DOI: https://doi.org/10.17712/nsj.2024.2.20230091

References

  1. 1.↵
    1. Ostrom QT,
    2. Cioffi G,
    3. Gittleman H,
    4. Patil N,
    5. Waite K,
    6. Kruchko C, et al.
    CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-oncology 2019; 21: v1–v100.
  2. 2.↵
    1. Backer-Grøndahl T,
    2. Moen BH,
    3. Torp SH.
    The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 2012; 5: 231.
    OpenUrlPubMed
  3. 3.↵
    1. Mair R,
    2. Morris K,
    3. Scott I,
    4. Carroll TA.
    Radiotherapy for atypical meningiomas. J Neurosurg 2011; 115: 811–819.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Pearson BE,
    2. Markert JM,
    3. Fisher WS,
    4. Guthrie BL,
    5. Fiveash JB,
    6. Palmer CA, et al.
    Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria: A case series. Neurosurgical focus 2008; 24: E3.
    OpenUrl
  5. 5.↵
    1. Endo T,
    2. Narisawa A,
    3. Ali HSM,
    4. Murakami K,
    5. Watanabe T,
    6. Watanabe M, et al.
    A study of prognostic factors in 45 cases of atypical meningioma. Acta Neurochir (Wien) 2016; 158: 1661–1667.
    OpenUrl
  6. 6.↵
    1. Loewenstern J,
    2. Shuman W,
    3. Rutland JW,
    4. Kessler RA,
    5. Kohli KM,
    6. Umphlett M, et al.
    Preoperative and histological predictors of recurrence and survival in atypical meningioma after initial gross total resection. World Neurosurg 2019; 128: e148–e156.
    OpenUrlPubMed
  7. 7.↵
    1. Buttrick S,
    2. Shah AH,
    3. Komotar RJ,
    4. Ivan ME.
    Management of atypical and anaplastic meningiomas. Neurosurg Clin N Am 2016; 27: 239–247.
    OpenUrlCrossRef
  8. 8.↵
    1. Couce M,
    2. Aker F,
    3. Scheithauer B.
    Chordoid meningioma: a clinicopathologic study of 42 cases. Am J Surg Pathol 2000; 24: 899–905.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Epari S,
    2. Sharma M,
    3. Sarkar C,
    4. Garg A,
    5. Gupta A,
    6. Mehta V.
    Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J Neurooncol 2006; 78: 263–269.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Louis DN,
    2. Perry A,
    3. Wesseling P,
    4. Brat DJ,
    5. Cree IA,
    6. Figarella-Branger D, et al.
    The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021; 23: 1231–1251.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Mawrin C,
    2. Perry A.
    Pathological classification and molecular genetics of meningiomas. J Neurooncol 2010; 99: 379–391.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Engenhart-Cabillic R,
    2. Farhoud A,
    3. Sure U,
    4. Heinze S,
    5. Henzel M,
    6. Mennel H-D, et al.
    Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 2006; 182: 641–646.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Perry A,
    2. Stafford SL,
    3. Scheithauer BW,
    4. Suman VJ,
    5. Lohse CM.
    Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997; 21: 1455–1465.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Ros-Sanjuan A,
    2. Iglesias-Moroño S,
    3. Carrasco-Brenes A,
    4. Bautista-Ojeda D,
    5. Arraez-Sanchez MA.
    Atypical meningiomas: histologic and clinical factors associated with recurrence. World Neurosurg 2019; 125: e248–e256.
    OpenUrl
  15. 15.↵
    1. Spille DC,
    2. Heß K,
    3. Sauerland C,
    4. Sanai N,
    5. Stummer W,
    6. Paulus W, et al.
    Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis. World Neurosurg 2016; 93: 346–354.
    OpenUrl
  16. 16.↵
    1. Wang F,
    2. Xu D,
    3. Liu Y,
    4. Lin Y,
    5. Wei Q,
    6. Gao Q, et al.
    Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Acta Neurochir (Wien) 2019; 161: 2563–2570.
    OpenUrl
  17. 17.↵
    1. Heald JB,
    2. Carroll TA,
    3. Mair RJ.
    Simpson grade: an opportunity to reassess the need for complete resection of meningiomas. Acta Neurochir (Wien) 2014; 156: 383–388.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Jenkinson MD,
    2. Weber DC,
    3. Haylock BJ,
    4. Mallucci CL,
    5. Zakaria R,
    6. Javadpour M.
    Atypical meningoma: current management dilemmas and prospective clinical trials. Journal of neuro-oncology 2015; 121: 1–7.
    OpenUrl
  19. 19.↵
    1. Hale AT,
    2. Wang L,
    3. Strother MK,
    4. Chambless LB.
    Differentiating meningioma grade by imaging features on magnetic resonance imaging. J Clin Neuroscie 2018; 48: 71–75.
    OpenUrl
  20. 20.
    1. Ruiz J,
    2. Martínez A,
    3. Hernández S,
    4. Zimman H,
    5. Ferrer M,
    6. Fernández C, et al.
    Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Histol Histopathol 2010; 25: 341–349.
    OpenUrlPubMed
  21. 21.↵
    1. Kano H,
    2. Takahashi JA,
    3. Katsuki T,
    4. Araki N,
    5. Oya N,
    6. Hiraoka M, et al.
    Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 2007; 84: 41–47.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Nanda A,
    2. Bir SC,
    3. Konar S,
    4. Maiti T,
    5. Kalakoti P,
    6. Jacobsohn JA, et al.
    Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence. J Clin Neurosc 2016; 31: 112–121.
    OpenUrl
  23. 23.↵
    1. Narayan V,
    2. Bir SC,
    3. Mohammed N,
    4. Savardekar AR,
    5. Patra DP,
    6. Nanda A.
    Surgical management of giant intracranial meningioma: operative nuances, challenges, and outcome. World Neurosurg 2018; 110: e32–e41.
    OpenUrl
  24. 24.↵
    1. Kim D,
    2. Niemierko A,
    3. Hwang WL,
    4. Stemmer-Rachamimov AO,
    5. Curry WT,
    6. Barker FG, et al.
    Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg 2018; 128: 1123–1132.
    OpenUrl
  25. 25.↵
    1. Hwang WL,
    2. Marciscano AE,
    3. Niemierko A,
    4. Kim DW,
    5. Stemmer-Rachamimov AO,
    6. Curry WT, et al.
    Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro-oncology 2016; 18: 863–872.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Lamba N,
    2. Hwang WL,
    3. Kim DW,
    4. Niemierko A,
    5. Marciscano AE,
    6. Mehan Jr WA, et al.
    Atypical histopathological features and the risk of treatment failure in nonmalignant meningiomas: a multi-institutional analysis. World Neurosurg 2020; 133: e804–e812.
    OpenUrl
  27. 27.↵
    1. Karabagli P,
    2. Karabagli H,
    3. Mavi Z,
    4. Demir F,
    5. Ozkeles EY.
    Histopathological and clinical features as prognostic factors of atypical meningiomas. Turk Neurosurg 2020; 30: 746–575.
    OpenUrl
  28. 28.↵
    1. Lee KD,
    2. DePowell JJ,
    3. Air EL,
    4. Dwivedi AK,
    5. Kendler A,
    6. McPherson CM.
    Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurgical focus 2013; 35: E15.
    OpenUrl
  29. 29.
    1. Durand A,
    2. Labrousse F,
    3. Jouvet A,
    4. Bauchet L,
    5. Kalamaridès M,
    6. Menei P, et al.
    WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 2009; 95: 367–375.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section